Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma
Clinical trial NCT05294055 · RECRUITING
Trial details
- NCT number
- NCT05294055
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2026-03-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.